By Finance Pulse in Stock Market —

Sangamo Shares Plummet After Pfizer Ends Collaboration

Sangamo Therapeutics' stock nosedives over 50% as Pfizer halts partnership on hemophilia drug. Discover the implications for Sangamo's future and investor concerns.

An artistic representation of a stock market graph with a dramatic downward trend, symbolizing the f
Sangamo Shares Plummet After Pfizer Ends Collaboration

Sangamo Therapeutics shares fell over 50% following Pfizer's decision to end their collaboration on a hemophilia drug.

Source